FDA recall Z-1195-2018

Roche Molecular Systems, Inc. · Class II · device

Product

Nucleic Acid test intended for screening for MRSA/SA. Each kit has 20 tubes. in vitro diagnostic.

Reason for recall

The cobas MRSA/SA tests may have decreased performance compared to the analytical sensitivity for MSRA detection. A screening failure can lead to potential infection in the colonized patient being tested as well as the spread of MSRA to others. The United States is not impacted, as the cobas MRSA/SA nucleic acid test for use on the cobas liat system is not available in the US.

Distribution

Worldwide distribution. Austria, Denmark, Germany, Singapore, Netherlands, Hong Kong, and Switzerland. US product is not affected.

Key facts

Status
Terminated
Initiation date
2017-10-27
Report date
2018-04-04
Termination date
2020-04-27
Voluntary/Mandated
Voluntary: Firm initiated
Location
Branchburg, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1195-2018